Development and validation of a LC-MS/MS method for quantitation of paroxetin in human plasma
Main Article Content
Abstract
A fast, simple, high throughput and specific method using ultra performance liquid chromatography tandem mass spectrometry was developed for quantitation of paroxetine in human plasma. The Waters Xevo TQD UPLC-MS/MS was operated under the multi reaction-monitoring mode (MRM 330.1>>192.1 for paroxetine và MRM 334.1>>196.1 for paroxetine-d4) using positive electrospray ionization technique. Paroxetine and internal standard – paroxetine-d4 were extracted from human plasma by liquid-liquid extraction. The samples were chromatographed on a C18 column (dimention 50 x 3 mm, particle 2.5 µm) at a flow rate of 0.2 mL/min using 20 mM ammonium formate solution – acetonitrile at ratio of 15 : 85. The calibration curves were found to be linear in the range 0.05 to 20 ng/mL, with mean correlation coefficient of > 0.999. The accuracy was within 85% – 115.0% and the precision was less than 15%. Total run time was 2.5 min. This method can be used for BA-BE studies of paroxetine preparations.
Article Details
Keywords
Paroxetine, LC-MS/MS, Human plasma
References
2. Massaroti P, Cassiano NM, Duarte LF, Campos DR, Marchioretto MA, Bernasconi G, Calafatti S, Barros FA, Meurer EC, Pedrazzoli J. Validation of a selective method for determination of paroxetine in human plasma by LC-MS/MS. J Pharm Pharm Sci. 2005 Aug 17;8(2):340-7. PMID: 16124946.
3. Jhee Ok; Seo HK; Lee MH; Jeon YC; Shaw LM; Lee SH; Hur Y; Kim KH; Lee HS; Lee SE; Kang JS (2011). Determination of Paroxetine in Plasma by Liquid Chromatography Coupled to Tandem Mass Spectrometry for Pharmacokinetic and Bio equivalence Studies. Arzneimittelforschung, 57(7), 455–461. Doi:10.1055/s-0031-1296631
4. U.S. Department of Health and Human Services Food and Drug Administration: Draft Guidance on Paroxetine Hydrochloride. October 2024
5. U.S. Department of Health and Human Services Food and Drug Administration (2018). Guidance for Industry - Bioanalytical Method Validation.
6. European Medicines Agency, Committee for Medicinal Products for Human Use (2012). Guideline on Validation of Bioanalytical Methods.
7. Chi J, Kim MY, Li F (2019) Quantitation of Paroxetine in Human Plasma by LC-MS/MS: Overcoming Significant Column-toColumn Retention Time Variation. J Chromatogr Sep Tech 10: 419. Doi:10.4172/2157-7064.1000419
8. Hiten J Shah, Mohan L Kundlik, Abhijit Kakad, Nitesh K Patel, Ankit Pandya, Vanita Khatri, Shivkumat Prajapati, Gunta Subbaiah, Chhagan N Patel, Quantification of Paroxetine in Human Plasma by Liquid Chromatography Coupled with Electrospray Ionization Tandem Mass Spectrometry, Journal of AOAC INTERNATIONAL. https://doi.org/10.1093/jaoac/93.1.141
9. Wang M, Zhou WJ, Zhang QY, Huang M. (2013). Development and Validation of a LC–MS/MS Method. Advanced Materials Research. Doi: 10.4028/www.scientific.net/AMR.722.255.
10. López-Calull C, Dominguez N, Determination of paroxetine in plasma by high-performance liquid chromatography for bioequivalence studies, Journal of Chromatography B: Biomedical Sciences and Applications, ISSN 0378-4347. https://doi. org/10.1016/S0378-4347(98)